相似文献
1
Radio(chemo)therapy in locally advanced nonsmall cell lung cancer.
Eur Respir Rev. 2016 Mar;25(139):65-70. doi: 10.1183/16000617.0053-2015.
2
Chemoradiotherapy for stage III non-small cell lung cancer: have we reached the limit?
Chin Clin Oncol. 2015 Dec;4(4):45. doi: 10.3978/j.issn.2304-3865.2015.11.04.
3
Induction chemotherapy with cetuximab, vinorelbine-cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine-cisplatin in patients with unresectable stage III non-small cell lung cancer.
Lung Cancer. 2015 Sep;89(3):249-54. doi: 10.1016/j.lungcan.2015.06.004. Epub 2015 Jun 17.
4
Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study.
BMC Cancer. 2013 Oct 12;13:474. doi: 10.1186/1471-2407-13-474.
5
A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501.
Lung Cancer. 2015 Feb;87(2):141-7. doi: 10.1016/j.lungcan.2014.11.001. Epub 2014 Nov 8.
6
Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
Thorac Cardiovasc Surg. 2018 Mar;66(2):135-141. doi: 10.1055/s-0037-1606597. Epub 2017 Oct 9.
7
Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
J Thorac Cardiovasc Surg. 2004 Jan;127(1):108-13. doi: 10.1016/j.jtcvs.2003.07.027.
8
Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study.
Anticancer Res. 2014 Apr;34(4):1959-66.
9
F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with concomitant chemotherapy: results of the PET-PLAN pilot trial.
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e283-9. doi: 10.1016/j.ijrobp.2011.01.020. Epub 2011 Apr 4.
10
Chemoradiotherapy of locally advanced nonsmall cell lung cancer: state of the art and perspectives.
Curr Opin Oncol. 2016 Mar;28(2):104-9. doi: 10.1097/CCO.0000000000000265.
引用本文的文献
1
Mixed radiation with different doses induces CCL17 to recruit CD8T cell to exert anti-tumor effects in non-small cell lung cancer.
Front Immunol. 2025 Jan 14;15:1508007. doi: 10.3389/fimmu.2024.1508007. eCollection 2024.
2
(-)-Epicatechin regulates endoplasmic reticulum stress and promotes ferroptosis in lung cancer cells via the PERK/eIF2α/ATF4 signaling pathway.
PLoS One. 2024 Oct 31;19(10):e0313010. doi: 10.1371/journal.pone.0313010. eCollection 2024.
3
Correlation Analysis of the TP53 Mutation With Clinical Characteristics in the Prognosis of Non-Small Cell Lung Cancer.
Clin Med Insights Oncol. 2023 Oct 9;17:11795549231184918. doi: 10.1177/11795549231184918. eCollection 2023.
4
Effect of Chemotherapy in Stage II-IV Large-Cell Lung Carcinoma and Construction of Its Predictive Nomograms: A SEER Analysis.
Med Princ Pract. 2023;32(1):49-60. doi: 10.1159/000529202. Epub 2023 Jan 18.
5
Characteristics of toxicity occurrence patterns in concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced non-small cell lung cancer: a pooled analysis based on individual patient data of CALGB/Alliance trials.
Transl Cancer Res. 2022 Oct;11(10):3506-3521. doi: 10.21037/tcr-22-2006.
6
Antiandrogen Therapy Radiosensitizes Androgen Receptor-Positive Cancers to F-FDG.
J Nucl Med. 2022 Aug;63(8):1177-1183. doi: 10.2967/jnumed.121.262958. Epub 2021 Nov 12.
7
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach.
PLoS One. 2019 Nov 13;14(11):e0224027. doi: 10.1371/journal.pone.0224027. eCollection 2019.
8
HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma.
Oncol Lett. 2019 Nov;18(5):4936-4946. doi: 10.3892/ol.2019.10812. Epub 2019 Sep 5.
9
Progress in image-guided radiotherapy for the treatment of non-small cell lung cancer.
World J Radiol. 2019 Mar 28;11(3):46-54. doi: 10.4329/wjr.v11.i3.46.
10
lncRNA Gm15290 promotes cell proliferation and invasion in lung cancer through directly interacting with and suppressing the tumor suppressor .
Biosci Rep. 2018 Oct 31;38(5). doi: 10.1042/BSR20181150.
本文引用的文献
1
Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.
Pract Radiat Oncol. 2015 May-Jun;5(3):141-148. doi: 10.1016/j.prro.2015.02.012.
2
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Lancet Oncol. 2015 Feb;16(2):187-99. doi: 10.1016/S1470-2045(14)71207-0. Epub 2015 Jan 16.
3
Locoregional tumor failure after definitive radiation for patients with stage III non-small cell lung cancer.
Radiat Oncol. 2014 Aug 26;9:187. doi: 10.1186/1748-717X-9-187.
4
Radiation dose effect in locally advanced non-small cell lung cancer.
J Thorac Dis. 2014 Apr;6(4):336-47. doi: 10.3978/j.issn.2072-1439.2014.01.23.
5
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer.
Cancer Med. 2013 Dec;2(6):916-24. doi: 10.1002/cam4.142. Epub 2013 Oct 16.
6
Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer.
J Clin Oncol. 2013 Dec 1;31(34):4343-8. doi: 10.1200/JCO.2013.51.5353. Epub 2013 Oct 21.
7
A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401.
Cancer Chemother Pharmacol. 2013 Dec;72(6):1247-54. doi: 10.1007/s00280-013-2308-5. Epub 2013 Oct 5.
8
Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis.
Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):690-6. doi: 10.1016/j.ijrobp.2013.07.029. Epub 2013 Sep 10.
9
Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.
Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):665-70. doi: 10.1016/j.ijrobp.2013.03.035. Epub 2013 May 18.
10
Long-term survival with surgery as part of a multimodality approach for N3 lung cancer.
Eur J Cardiothorac Surg. 2013 Dec;44(6):1117-22. doi: 10.1093/ejcts/ezt171. Epub 2013 Mar 29.
Zotero 插件